GSK posts COPD win for Nucala as Sanofi-Regeneron rival Dupixent nears delayed FDA decision
GSK is heading into the weekend with a win for its respiratory blockbuster Nucala—but for now, the details are slim.
Continue Reading
BF Biosciences enters into agreement with Lucky Core Industries
Pakistan’s pharmaceutical company BF Biosciences Limited (BFBL) has entered into a contract manufacturing and supply agreement with Lucky Core Industries
Continue Reading
Ferozsons Laboratories’ subsidiary BF Biosciences launches human insulin
Pakistan’s pharmaceutical company BF Biosciences Limited (BFBL) has successfully launched a human insulin under the brand name ‘Ferulin’. The development
Continue Reading
Pakistan’s pharma company BF Biosciences looks to raise at least Rs1.38bn through IPO
Pakistan’s pharmaceutical company BF Biosciences Limited (BFBL) is planning an initial public offering (IPO) at the Pakistan Stock Exchange (PSX)
Continue Reading
BF Biosciences gets DRAP nod for brownfield expansion
Pakistan’s pharmaceutical company BF Biosciences Limited (BFBL) has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for brownfield
Continue Reading